ALS News

New Promising Neurological Treatment for Alzheimer's used in ALS in Phase 2 Clinical Trials

ALS NEWS - September 13, 2020

Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects 400,000 people worldwide. It is characterized by progressive loss... Read More

A Potential ALS Treatment is Back on Track After COVID-19 Disruption

ALS NEWS - August 31, 2020

This global pandemic has put a lot of things on pause. From sports to drug research, the world is doing a complete reboot. One of the biggest setbacks is fundin... Read More

Clene Nanomedicine Develops New Therapy for ALS Using Gold Nanocrystals

ALS NEWS - August 29, 2020

Clene Nanotechnologies, a Utah based company, has developed a nano-therapetic for neurodegenerative disorders including ALS. To date, Clene's preclinical tr... Read More

New Promising Neurological Treatment Involves ALS in Phase 2 Clinical Trials

ALS NEWS - August 28, 2020

Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects 400,000 people worldwide. It is characterized by progressive loss... Read More

ALS Clinical Trials Actively Recruiting

ALS NEWS - August 05, 2020

ALS Crowd is dedicated to connecting researchers, doctors, patients, and caregivers/family members in order to support, educate, and find patterns in therapy to... Read More

Uncovering the Benefits of Riluzole for ALS Patients

ALS NEWS - August 01, 2020

Riluzole is the only FDA-approved drug therapy for ALS patients. The American Academy of Neurology recommends that Riluzole should be offered to ... Read More

New Breakthrough in Silencing ALS Gene SOD1

ALS NEWS - July 14, 2020

ALS is generally classified into two categories, familial or hereditary ALS and sporadic or non-hereditary ALS. Those with familial ALS (fALS) have mutations in... Read More

New Cells Discovered to be Involved in ALS

ALS NEWS - July 08, 2020

Brown University researchers identified specific cells (glial cells) within the nervous system cells as a potential source of decay in diseases like ALS. T... Read More

Pimozide May Provide Better Quality of Life for ALS patients

ALS NEWS - June 18, 2020

Pimozide is a drug currently being used to suppress the physical (motor) and vocal (phonic) symptoms of tics when these symptoms interfere with daily life ... Read More

Genetic Mutation Affecting Proteins Could Cause ALS

ALS NEWS - June 14, 2020

  Over 5,000 people are diagnosed with ALS each year in the United States. Amyotrophic Lateral Sclerosis is a disease that attacks the very roots of hum... Read More

It is time to ACT against ALS!

ALS NEWS - June 10, 2020

Two pieces of legislation are making their way through congress that could drastically improve the lives of those with ALS. The first is a bill intended to... Read More

Microorganism Involvement in ALS Progression

ALS NEWS - May 31, 2020

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that affects the motor neurons in the central nervous system. For years, researchers have bee... Read More

FDA Approves Masitinib for a Phase 3 ALS Clinical Trial

ALS NEWS - May 30, 2020

AB Science, a clinical stage pharmaceutical company, received clearance on their application to use masitinib in an upcoming 3 phase clinical trial to... Read More